We searched PubMed with the terms “metabolic syndrome”, “insulin resistance”, “coronary heart disease”, “diabetes mellitus”, “inflammation”, “hypertension”, “insulin secretion”, “CRP”, “cytokines”, and “adiponectin”.
SeminarThe metabolic syndrome
Section snippets
Defining the metabolic syndrome
While the concept of the metabolic syndrome was accepted, and even while controversies have raged about its cause, it was not until 1998 that there was an initiative to develop an internationally recognised definition. In an attempt to achieve some agreement on definition, and to provide a tool for clinicians and researchers, a WHO consultation proposed a set of criteria.13 Subsequently, the National Cholesterol Education Program's Adult Treatment Panel III (NCEP: ATP III)14 and the European
Prevalence
Comparisons of published prevalence for different populations are difficult despite attempts to reach agreement on the definition of the metabolic syndrome.1 Many studies compare prevalences using different criteria, and perhaps their main achievement is to reinforce the need for a standardised international definition. Cameron and others1 have published a detailed review about the prevalence of the syndrome with different criteria (table 1).
Figure 1 presents studies from various countries.
Relation to predictability of diabetes and cardiovascular disease
The metabolic syndrome is associated with an increased risk of both diabetes5 and cardiovascular disease.9, 10, 28, 29 Several studies have indicated that the metabolic syndrome predicts future diabetes.30, 31 However, since impaired fasting glucose and impaired glucose tolerance are components of the NCEP:ATP-III and the WHO definitions respectively, this finding might not be a surprise.
In the DECODE study involving European men and women,32 non-diabetic people with the metabolic syndrome had
Insulin resistance
The most accepted and unifying hypothesis to describe the pathophysiology of the metabolic syndrome is insulin resistance. Insulin resistance has traditionally been defined with a glucocentric view—ie, when a defect in insulin action results in fasting hyperinsulinaemia to maintain euglycaemia. Yet, even before fasting hyperinsulinaemia develops, postprandial hyperinsulinaemia exists.
A major contributor to the development of insulin resistance is an overabundance of circulating fatty acids.
Beyond insulin resistance
Despite the substantial amount of evidence in support of the notion that the metabolic syndrome is an insulin resistance syndrome, quantification of insulin action in vivo is not always strongly related to the presence of the syndrome.111 Several key questions are raised. First, if the metabolic syndrome is a consequence of only insulin resistance, is the definition appropriately constructed? Second, is it possible that the current components and their relation to the metabolic syndrome exist
Management of metabolic syndrome
The presence of the metabolic syndrome carries increased risk for cardiovascular disease10, 118 and type 2 diabetes.117 Some affected people are at high or moderately high risk for major cardiovascular disease events in the short term (, ≤10 years); others are at less risk in the short term, but carry a fairly high long-term risk.119 In the latter group, therapeutic lifestyle modification is first-line therapy, but if 10-year risk is high, drug therapy to modify cardiovascular disease risk
Search strategy and selection criteria
References (164)
- et al.
The metabolic syndrome: prevalence in worldwide populations
Endocrinol Metab Clin North Am
(2004) - et al.
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
Diabetes Res Clin Pract
(2003) - et al.
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Am J Cardiol
(2004) - et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Lancet
(2004) - et al.
Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3
J Biol Chem
(2002) - et al.
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids
J Biol Chem
(2003) - et al.
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
J Biol Chem
(2004) - et al.
Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome
J Thromb Haemost
(2003) - et al.
Lipodystrophies: rare disorders causing metabolic syndrome
Endocrinol Metab Clin North Am
(2004) Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome
Trends Endocrinol Metab
(2003)
Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance
J Biol Chem
Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia
Clin Chim Acta
Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels
Atherosclerosis
Dense low density lipoproteins and coronary artery disease
Am J Cardiol
Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue
J Biol Chem
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
Mol Cell
Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
Cell
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
Clin Liver Dis
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
Hepatology
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
Atherosclerosis
Studien. Hypertonie-Hyperglykamie-Hyperurikamiesyndrome
Zentralblatt fur innere Medizin
La differenciation sexuelle, facteur determinant des formes de l'obesite
Presse Med
Global and societal implications of the diabetes epidemic
Nature
Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management
Circulation
Banting lecture 1988. Role of insulin resistance in human disease
Diabetes
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
Diabetes Care
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Arch Intern Med
Cardiovascular morbidity and mortality associated with the metabolic syndrome
Diabetes Care
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
JAMA
Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
Circulation
Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit?
Diabetes Care
Definition, diagnosis and classification of diabetes mellitus and its complications. Part1 diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
Diabet Med
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
JAMA
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)
Diabet Med
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
Diabetologia
American College of Endocrinology position statement on the insulin resistance syndrome
Endocr Pract
Obesity: mechanisms and clinical management
The Asia-Pacific Perspective. Redefining Obesity and its Treatment
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
Lancet
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey
JAMA
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
N Engl J Med
National surveillance for type 2 diabetes mellitus in Taiwanese children
JAMA
High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9–12 years
Diabetes Care
Obesity and the metabolic syndrome in children and adolescents
N Engl J Med
Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994
Arch Pediatr Adolesc Med
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
Circulation
Components of the “metabolic syndrome” and incidence of type 2 diabetes
Diabetes
Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study
Am J Epidemiol
Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women
Arch Intern Med
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
Diabet Med
Cited by (5275)
Prevalence and correlates of metabolic syndrome among adults in freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and harmonized ATP III criteria
2024, International Journal of Cardiology: Cardiovascular Risk and PreventionEmpowering mitochondrial metabolism: Exploring L-lactate supplementation as a promising therapeutic approach for metabolic syndrome
2024, Metabolism: Clinical and Experimental